---
$id: https://graph.org.ai/products/commodity/51161534
$type: Product
source: UNSPSC
code: "51161534"
title: "Denbufylline"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Denbufylline

**UNSPSC Code**: 51161534
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor with the molecular formula C16H24N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 04B949KO6F, chemically known as 3,7-dihydro-1,3-dibutyl-7-(2-oxopropyl)-1h-purine-2,6-dione but generally known as denbufylline, which bears US NIH Compound Identifier 2984. European Medicines Agency schedules Denbufylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06974MIG. The term DENBUFYLLINE is an International Non-Proprietary Name. DENBUFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule denbufylline under HS 29395900 and SITC 54145. As of Q4 2014, DENBUFYLLINE remains the US FDA Preferred Term for this commodity. Denbufylline bears US NLM identifiers UMLS ID C0057384 and NCI Concept Code C76316. SMILES: O=C1N(C2NCN(C2C(=O)N1CCCC)CC(=O)C)CCCC.

